CDMO

biotech investment
Manufacturing

Wilmington PharmaTech to spend $50M on API production expansion

CDMO Wilmington PharmaTech will drop $50 million in a move to double the current production capacity at its Delaware facility.
Joseph Keenan Mar 24, 2026 11:37am
WuXi

WuXi Bio's contracting business saw influx of US clients in '25

Mar 24, 2026 10:56am
FDA stop sign

FDA scolds Simtra with warning letter for contamination issues

Mar 13, 2026 11:00am
manufacturing drug manufacturing pharma manufacturing assembly line

Forma Life Sciences launches into class of new CDMOs

Mar 5, 2026 12:42pm
A landscape view of evening in Taipei City Taiwan The building lights are lit and the sun is nearly done setting

BioDuro enters Taiwan API joint venture

Mar 4, 2026 2:56pm
two jiggsaw puzzles connected with drawn hands shaking on the two puzzles

CDMO Quotient extends Ipsen supply deal for rare disease drug

Mar 2, 2026 11:00am